CVE:VPT VentriPoint Diagnostics (VPT) Stock Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free VPT Stock Alerts C$0.22 +0.02 (+7.14%) (As of 05:33 PM ET) Add Compare Share Share Today's RangeC$0.21▼C$0.2350-Day RangeC$0.21▼C$0.3252-Week RangeC$0.12▼C$0.36Volume146,000 shsAverage Volume99,302 shsMarket CapitalizationC$35.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades Get VentriPoint Diagnostics alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About VentriPoint Diagnostics Stock (CVE:VPT)Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.Read More VPT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VPT Stock News HeadlinesApril 23, 2024 | insidertrades.comInsider Buying: VentriPoint Diagnostics Ltd. (CVE:VPT) Director Buys 75,000 Shares of StockApril 17, 2024 | americanbankingnews.comVentriPoint Diagnostics (CVE:VPT) Trading Up 4.8%April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? April 14, 2024 | morningstar.comVentriPoint Diagnostics Ltd VPTMarch 28, 2024 | finance.yahoo.comVentripoint Diagnostics Provides Corporate Update and Announces Conference CallMarch 4, 2024 | stockhouse.comEnhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to UseFebruary 21, 2024 | benzinga.comVentriPoint Diagnostics Stock (OTC:VPTDF) Dividends: History, Yield and DatesFebruary 14, 2024 | morningstar.comVentriPoint Diagnostics Ltd VPTDFApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? February 13, 2024 | stockhouse.comVentripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global SalesFebruary 1, 2024 | es-us.finanzas.yahoo.comThe Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging SystemJanuary 29, 2024 | finance.yahoo.comThe 2023 Year in ReviewDecember 12, 2023 | theglobeandmail.comHealthcare Stock Rallies Strongly Following Key ImplementationDecember 5, 2023 | finance.yahoo.comOllie Hinkle Heart Foundation will Introduce Ventripoint's AI-Heart-Imaging Diagnostic Technology to America's HospitalsNovember 5, 2023 | morningstar.comAccelerate Diagnostics Inc AXDXOctober 4, 2023 | seekingalpha.comVentripoint Diagnostics appoints Jimmy Jeon as CFOAugust 31, 2023 | seekingalpha.comVentriPoint Diagnostics reports Q2 resultsAugust 22, 2023 | finance.yahoo.comVentripoint Welcomes Evelina London Children's Hospital as Newest VMS+ UserAugust 18, 2023 | finance.yahoo.comVentripoint Unveils New Integrated Product with ASCEND CardiovascularAugust 10, 2023 | finance.yahoo.comVentripoint Announces Collaboration with Ascend CardiovascularJuly 18, 2023 | finance.yahoo.comVentripoint's VMS+ Purchased by Medical Center - University of FreiburgJuly 15, 2023 | theglobeandmail.comClosing Bell: Ventripoint Diagnostics Ltd flat on Friday (VPT)May 23, 2023 | ca.finance.yahoo.comVentriPoint Diagnostics Ltd. (VPTDF)May 2, 2023 | theglobeandmail.comClosing Bell: Ventripoint Diagnostics Ltd down on Monday (VPT)April 29, 2023 | theglobeandmail.comClosing Bell: Ventripoint Diagnostics Ltd up on Friday (VPT)April 28, 2023 | theglobeandmail.comClosing Bell: Ventripoint Diagnostics Ltd down on Thursday (VPT)April 27, 2023 | theglobeandmail.comClosing Bell: Ventripoint Diagnostics Ltd up on Wednesday (VPT)See More Headlines Receive VPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VentriPoint Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Next Earnings (Estimated)5/02/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolCVE:VPT CUSIPN/A CIKN/A Webwww.ventripoint.com Phone416-848-4156FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-4,740,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-141.63% Return on Assets-63.46% Debt Debt-to-Equity Ratio32.61 Current Ratio2.06 Quick Ratio6.67 Sales & Book Value Annual SalesC$24,600.00 Price / Sales1,338.71 Cash FlowC$0.04 per share Price / Cash Flow5.53 Book ValueC$0.01 per share Price / Book21.00Miscellaneous Outstanding Shares156,820,000Free FloatN/AMarket CapC$32.93 million OptionableNot Optionable Beta0.39 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. George Adams B.A.Sc. (Age 76)ICD.D., M.A.Sc., Ph.D., Executive Chairman & Corporate Secretary Comp: $286kMr. Hugh MacNaughtInterim CEO, President & DirectorMr. Jimmy JeonChief Financial OfficerMr. Hirotaka KatagiriCTO & Business Development Division DirectorMr. Jim GrabaApplication Specialist & Chief TrainerKey CompetitorsTheralase TechnologiesCVE:TLTHelius Medical TechnologiesTSE:HSMMedX HealthCVE:MDXAurora SpineCVE:ASGProtech Home MedicalCVE:PHMView All CompetitorsInsidersRobert HodgkinsonBought 4,500 shares on 4/26/2024Total: C$945.00 ($0.21/share)Robert HodgkinsonBought 21,000 shares on 4/24/2024Total: C$4,410.00 ($0.21/share)Robert HodgkinsonBought 75,000 shares on 4/22/2024Total: C$15,900.00 ($0.21/share)Robert HodgkinsonBought 36,500 shares on 4/18/2024Total: C$7,774.50 ($0.21/share)Hugh MacnaughtBought 20,000 shares on 4/12/2024Total: C$4,400.00 ($0.22/share)View All Insider Transactions VPT Stock Analysis - Frequently Asked Questions How have VPT shares performed in 2024? VentriPoint Diagnostics' stock was trading at C$0.30 at the beginning of 2024. Since then, VPT shares have decreased by 23.7% and is now trading at C$0.23. View the best growth stocks for 2024 here. When is VentriPoint Diagnostics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our VPT earnings forecast. What other stocks do shareholders of VentriPoint Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other VentriPoint Diagnostics investors own include Resverlogix (RVX), AuRico Gold Inc. Ordinary Share (AUQ), Kootenay Silver (KTN), ProMetic Life Sciences (PLI), Shopify (SHOP), Shockwave Medical (SWAV), Barkerville Gold Mines Ltd. (BGM.V) (BGM), Bird Construction (BDT), Bombardier, Inc. Class B (BBD.B) and How do I buy shares of VentriPoint Diagnostics? Shares of VPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:VPT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VentriPoint Diagnostics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
